An FDA Advisory Panel Votes Against A Booster Of The Pfizer Vaccine
A panel of advisers to the Food and Drug Administration voted against a booster dose of the Pfizer-BioNTech COVID-19 vaccine be licensed for people 16 years and older.
A panel of advisers to the Food and Drug Administration voted against a booster dose of the Pfizer-BioNTech COVID-19 vaccine be licensed for people 16 years and older.
You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002
No comments:
Post a Comment